On Tuesday, Barclays reiterated its 'overweight' recommendation on Eurofins Scientific shares, while adjusting its price target to 60 euros, from 70 euros previously.

In a research note released in the morning, the British investment bank points out that Q3 results, like the group's recent investor day, have highlighted progress on pricing and an increased focus on profit margins in Europe.

Despite the volatility of its share price, Eurofins is a sustainable and defensive company which we believe will be able to generate a total shareholder return (TSR) of around 15% over the coming years", emphasizes Barclays.

Copyright (c) 2023 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.